Loading
Latest filing published 04 Nov 2021 for Telo Genomics Corp., €38k.
Hugh Allison Douglas Rogers discloses dealings in Telo Genomics Corp. to SEDI. Over a trading history stretching from 17 September 2018 to 29 October 2021, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 4 November 2021: an option exercise of €38k, in Telo Genomics Corp. Filings reach the SEDI feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations